NPTX — Neuropathix Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Neuropathix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2017 December 31st	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	0.002	2.89	0.121	0.022	0.016
Net Total Accounts Receivable
Net Total Receivables	0	0.116	0	0	0
Prepaid Expenses
Total Current Assets	0.002	3	0.131	0.183	0.138
Net Property, Plant And Equipment	—	0.003	0.075	0.059	0.069
Long Term Investments
Other Long Term Assets
Total Assets	0.002	3.02	0.223	0.26	0.225
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.051	0.546	1.33	2.55	2.98
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	0.051	1.69	1.92	3.45	4.21
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-0.049	1.34	-1.69	-3.19	-3.99
Total Liabilities & Shareholders' Equity	0.002	3.02	0.223	0.26	0.225
Total Common Shares Outstanding